In our case, the absence of shared driver mutations (JAK2/CALR/MPL in ET vs. SETD2/IKZF1 in ALL) supports clonal independence, consistent with prior reports of MPL- or JAK2-mutated ET progressing to Ph+ B-ALL (12, 13, 15). The gene discussed is IKZF1; the disease is acute lymphoblastic leukemia.